BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35804981)

  • 1. Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters.
    Reiser E; Pils D; Grimm C; Hoffmann I; Polterauer S; Kranawetter M; Aust S
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-glutamyltransferase as a preoperative differential diagnostic marker in patients with adnexal mass.
    Reiser E; Aust S; Seebacher V; Reinthaller A; von Mersi H; Schwameis R; Polterauer S; Grimm C; Helmy-Bader S
    Eur J Obstet Gynecol Reprod Biol; 2019 Aug; 239():16-20. PubMed ID: 31158789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology.
    Van Holsbeke C; Van Belle V; Leone FP; Guerriero S; Paladini D; Melis GB; Greggi S; Fischerova D; De Jonge E; Neven P; Bourne T; Valentin L; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2010 Jul; 36(1):81-7. PubMed ID: 20217895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign, Borderline, and Malignant Pediatric Adnexal Masses: A 10-Year Review.
    Xac MC; Jetelina KK; Jarin J; Wilson E
    J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):454-461. PubMed ID: 33453397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative C-reactive protein serum levels as a predictive diagnostic marker in patients with adnexal masses.
    Reiser E; Aust S; Seebacher V; Reinthaller A; Helmy-Bader S; Schwameis R; Grimm C; Polterauer S
    Gynecol Oncol; 2017 Dec; 147(3):690-694. PubMed ID: 28935270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sonographic diagnosis of presumed benign ovarian tumors].
    Marret H; Cayrol M
    J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):730-43. PubMed ID: 24200073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADC-derived spatial features can accurately classify adnexal lesions.
    Fathi Kazerooni A; Nabil M; Haghighat Khah H; Alviri M; Heidari-Sooreshjaani M; Gity M; Malek M; Saligheh Rad H
    J Magn Reson Imaging; 2018 Apr; 47(4):1061-1071. PubMed ID: 28901638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
    Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Doppler ultrasonography in the diagnosis of ovarian cysts: indications, pertinence and diagnostic criteria].
    Marret H
    J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(1 Suppl):S20-33. PubMed ID: 11917373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China.
    He P; Wang JJ; Duan W; Song C; Yang Y; Wu QQ
    J Ovarian Res; 2021 Dec; 14(1):169. PubMed ID: 34857005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational study.
    Stukan M; Badocha M; Ratajczak K
    BMC Cancer; 2019 Jun; 19(1):564. PubMed ID: 31185938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses.
    Dolgun ZN; Kabaca C; Karateke A; İyibozkurt C; İnan C; Altıntaş AS; Karadağ C
    Balkan Med J; 2017 Apr; 34(2):156-162. PubMed ID: 28418343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying tumor vascular heterogeneity with DCE-MRI in complex adnexal masses: A preliminary study.
    Thomassin-Naggara I; Soualhi N; Balvay D; Darai E; Cuenod CA
    J Magn Reson Imaging; 2017 Dec; 46(6):1776-1785. PubMed ID: 28370815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group.
    Timmerman D; Ameye L; Fischerova D; Epstein E; Melis GB; Guerriero S; Van Holsbeke C; Savelli L; Fruscio R; Lissoni AA; Testa AC; Veldman J; Vergote I; Van Huffel S; Bourne T; Valentin L
    BMJ; 2010 Dec; 341():c6839. PubMed ID: 21156740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Malignancy in Adnexal Masses by the International Ovarian Tumor Analysis-Simple Rules.
    Solanki V; Singh P; Sharma C; Ghuman N; Sureka B; Shekhar S; Gothwal M; Yadav G
    J Midlife Health; 2020; 11(4):217-223. PubMed ID: 33767562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in perioperative outcomes after laparoscopic management of benign and malignant adnexal masses.
    Gad MS; El Khouly NI; Soto E; Brodman M; Chuang L; Nezhat FR; Gretz HF
    J Gynecol Oncol; 2011 Mar; 22(1):18-24. PubMed ID: 21607091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the predictive performance of risk of malignancy indexes 1-4, HE4 and risk of malignancy algorithm in the triage of adnexal masses.
    Hada A; Han LP; Chen Y; Hu QH; Yuan Y; Liu L
    J Ovarian Res; 2020 Apr; 13(1):46. PubMed ID: 32334618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.